Literature DB >> 29472828

Successfully Integrating Radium Ra 223 Dichloride Injection Into a Urology Practice.

Gregory C McMahon1, Gordon A Brown2.   

Abstract

Entities:  

Year:  2017        PMID： 29472828      PMCID： PMC5811882          DOI： 10.3909/riu0782

Source DB:  PubMed          Journal:  Rev Urol        ISSN： 1523-6161


× No keyword cloud information.
  11 in total

Review 1.  Regulation of tumor cell plasticity by the androgen receptor in prostate cancer.

Authors:  Jennifer L Bishop; Alastair Davies; Kirsi Ketola; Amina Zoubeidi
Journal:  Endocr Relat Cancer       Date:  2015-05-01       Impact factor: 5.678

Review 2.  Clinical phenotypes of castration-resistant prostate cancer.

Authors:  Tian Zhang; Andrew J Armstrong
Journal:  Clin Adv Hematol Oncol       Date:  2013-11

3.  Radium Ra 223 Dichloride Therapy in the Private Practice Environment.

Authors:  Jeffrey C Seeber
Journal:  Rev Urol       Date:  2016

4.  The Clinical and Economic Impacts of Skeletal-Related Events Among Medicare Enrollees With Prostate Cancer Metastatic to Bone.

Authors:  Jean A McDougall; Aasthaa Bansal; Bernardo H L Goulart; Jeannine S McCune; Andy Karnopp; Catherine Fedorenko; Stuart Greenlee; Adriana Valderrama; Sean D Sullivan; Scott D Ramsey
Journal:  Oncologist       Date:  2016-02-10

Review 5.  Multidisciplinary management of Prostate Cancer: how and why.

Authors:  Alessandro Sciarra; Vincenzo Gentile; Valeria Panebianco
Journal:  Am J Clin Exp Urol       Date:  2013-12-25

6.  Cancer Statistics, 2017.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2017-01-05       Impact factor: 508.702

7.  Alpha emitter radium-223 and survival in metastatic prostate cancer.

Authors:  C Parker; S Nilsson; D Heinrich; S I Helle; J M O'Sullivan; S D Fosså; A Chodacki; P Wiechno; J Logue; M Seke; A Widmark; D C Johannessen; P Hoskin; D Bottomley; N D James; A Solberg; I Syndikus; J Kliment; S Wedel; S Boehmer; M Dall'Oglio; L Franzén; R Coleman; N J Vogelzang; C G O'Bryan-Tear; K Staudacher; J Garcia-Vargas; M Shan; Ø S Bruland; O Sartor
Journal:  N Engl J Med       Date:  2013-07-18       Impact factor: 91.245

8.  Optimal management of metastatic castration-resistant prostate cancer: highlights from a European Expert Consensus Panel.

Authors:  John M Fitzpatrick; Joaquim Bellmunt; Karim Fizazi; Axel Heidenreich; Cora N Sternberg; Bertrand Tombal; Antonio Alcaraz; Amit Bahl; Sergio Bracarda; Giuseppe Di Lorenzo; Eleni Efstathiou; Stephen P Finn; Sophie Fosså; Silke Gillessen; Pirkko-Liisa Kellokumpu-Lehtinen; Frédéric E Lecouvet; Stephane Oudard; Theo M de Reijke; Craig N Robson; Maria De Santis; Bostjan Seruga; Ronald de Wit
Journal:  Eur J Cancer       Date:  2014-04-03       Impact factor: 9.162

9.  Prevalence of pain and analgesic use in men with metastatic prostate cancer using a patient-reported outcome measure.

Authors:  Karen A Autio; Antonia V Bennett; Xiaoyu Jia; Michael Fruscione; Tomasz M Beer; Daniel J George; Michael A Carducci; Christopher J Logothetis; Robert C Kane; Laura Sit; Lauren Rogak; Michael J Morris; Howard I Scher; Ethan M Basch
Journal:  J Oncol Pract       Date:  2013-06-25       Impact factor: 3.840
View more
  2 in total

1.  Evaluation of N-Succinimidyl S-Acetylthioacetate Ligand for Radiolabeling of Humanized Antibodies with 188Rhenium.

Authors:  Kevin J H Allen; Rubin Jiao; Mackenzie E Malo; Ekaterina Dadachova
Journal:  Cancer Biother Radiopharm       Date:  2018-07-16       Impact factor: 3.099

2.  Adverse Events Associated With Radium-223 in Metastatic Prostate Cancer: Disproportionality Analysis of FDA Data Reflecting Worldwide Utilization.

Authors:  Minh-Phuong Huynh-Le; Randall C Shults; Michael J Connor; Jona A Hattangadi-Gluth
Journal:  Clin Genitourin Cancer       Date:  2019-12-05       Impact factor: 2.872
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.